Willow Biosciences Inc.
Willow Biosciences Inc.
Indice CSE:
Devise:
Willow Biosciences are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opioid biosynthesis. We are now leveraging our unique design-build process to the biosynthesis of cannabinoids.
Willow Biosciences Inc. (WLLW)
SEDAR Information
Information d'entreprise
Addresse
3655 36th Street NW
Calgary, AB T2L 1Y8
CanadaTéléphone
403-669-4848Fax
1-587-779-6149Courriel
info@willowbio.comURL
http://www.willowbio.comDate d’inscription à la cote
Jeudi, septembre 14, 2017
Agent de transfert
Alliance Trust CompanyVérificateur
KPMG LLPCapitalisation
Capitalisation:
78,891,879Réservé à l'émission:
33,524,529Company Officers
Trevor Peters, President and Chief Executive Officer
Travis Doupe, Chief Financial Officer
Peter Facchini, Chief Scientific Officer
Jerry Ericsson, Vice President, Operations
Jill Hagel, Vice President, Applied Science
Mathias Schuetz, Vice President, Research and Development
Troy Talkkari, Vice President, Corporate Development
Joseph Tucker, Executive Chairman
Bulletins
Advertisement
Publicité
Évènements à venir
Capital Markets Comeback Tour
Mercredi, mai 11, 2022 (Jour entier) - Jeudi, juin 2, 2022 (Jour entier)
Vancouver Resource Investment Conference (VRIC)
Mardi, mai 17, 2022 - 08:30 - Mercredi, mai 18, 2022 - 17:30
Tech Tuesdays
Série
